Waters EBIT

The latest EBIT for WAT is $340M as of June 2026. That compares with $770M in the prior-year period — down 56.4% year over year. That is below the Healthcare sector average of $23B. Investors often review this figure alongside Waters's historical trend and sector peers before judging valuation or financial health.

Over the past year, WAT's EBIT moved from $770M to $340M — a 56.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Waters's operating scale or balance-sheet position.

Against Healthcare companies, WAT currently prints $340M for EBIT, while the sector average sits near $23B. That is roughly 98.5% below the sector mean. Large gaps often invite a closer look at Waters's growth, margins, and balance sheet.

A EBIT figure of $340M for WAT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.

After noting WAT's EBIT ($340M), review year-over-year change from $770M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.